Basecamp Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Basecamp Wealth Advisors's LLY Position: Q3 2026 in Review
Basecamp Wealth Advisors reduced its Eli Lilly (LLY) stake by 6.2% in Q3 2026, selling an estimated $1.06M and leaving 13,577 shares worth $15.7M. The position accounts for 3.59% of the portfolio, ranked #5.
Basecamp Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $17.4M in Q2 2026. 4,568 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Basecamp Wealth Advisors held 13,577 shares of Eli Lilly worth $15.7M as of Q3 2026.
- Basecamp Wealth Advisors sold 901 Eli Lilly shares in Q3 2026, an estimated $1.06M.
- Eli Lilly made up 3.59% of Basecamp Wealth Advisors's portfolio in Q3 2026, its #5 holding.
- Basecamp Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- Basecamp Wealth Advisors's Eli Lilly position peaked at $17.4M in Q2 2026.
- 4,568 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Basecamp Wealth Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.